Contraer la navegación.
Haleon plc (“Haleon”) today announces the appointment of Maria Paula Capuzzo as Chief Growth Officer and a member of the Haleon Executive Team. Maria Paula will join Haleon on 1 January 2027.
Maria Paula succeeds Filippo Lanzi, who will become President, Europe. Filippo agreed to lead Haleon’s newly established Growth function through 2026 and will hand over leadership to Maria Paula when she joins in January. He takes over from Jonathan Workman, who has decided to leave the business, having established the foundations of Haleon’s newly shaped Europe Operating Unit.
Maria Paula joins Haleon after spending almost three decades at Colgate-Palmolive, where her international career has spanned commercial leadership, innovation, marketing, brand building and general management, with a strong track record of driving transformation and accelerating sustainable growth. She brings significant emerging-market experience, most recently as President, Africa Eurasia Middle East, leading a business spanning c.100 markets, and previously as President of Colgate-Palmolive Brazil. Throughout her career, she has also held roles in the US, Switzerland, Central America and Mexico, giving her a broad perspective across developed and emerging markets.
As Chief Growth Officer, Maria Paula will lead Haleon’s Growth function and work with its Operating Units, R&D and Supply Chain to deliver sustainable growth. Her focus will combine deeper consumer understanding with strong customer partnerships, executional excellence and effective marketing investment.
Brian McNamara, Haleon’s Chief Executive Officer, commented: “We are delighted to welcome Maria Paula as Chief Growth Officer. Delivering sustainable growth is a clear priority for Haleon. Maria Paula will focus on strengthening our brands, identifying opportunities for growth through deeper consumer understanding, and accelerating and scaling innovation that meets people’s everyday health needs.”
“Jonathan has decided to leave Haleon, having established the foundations of our newly shaped Europe Operating Unit. I want to thank him personally for his commitment and contribution since 2010, including through our separation and the creation of Haleon, and wish him every success for the future. Filippo will lead Europe with a clear focus on accelerating growth, drawing on his experience leading our Asia Pacific and EMEA and Latin America businesses and establishing our Growth function.”
Maria Paula Capuzzo commented: “I am excited to join Haleon and contribute to the next phase of its growth. Haleon’s brands have long been trusted by consumers and their families, and there is an incredible opportunity to build on that trust and make an even greater difference to people’s everyday health with humanity. I look forward to listening and learning, working with colleagues across the business and helping to translate that opportunity into sustainable growth and a greater positive impact for the consumers and communities we serve.”
Ends
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion consumers and are recommended by health professionals around the world.